The clinical potential of etrolizumab in ulcerative colitis: hypes and hopes
2016-01-01 Fiorino, G; Gilardi, D; Danese, S
Are We Ready to Abandon Placebo in Randomised Clinical Trials for Inflammatory Bowel Disease? Pros and Cons
2016-01-01 Danese, S; Schabel, E; Masure, J; Plevy, S; Schreiber, S
A liophylized and inactivated colture of Lactobacillus acidophilus increases Helicobacter pylori eradication rate
2000-01-01 Canducci, F; Armuzzi, A; Cremonini, F; Candelli, M; Ojetti, V; Di Campli, C; Gabrielli, M; Danese, S; Pola, P; Gasbarrini, G; Gasbarrini, A
Budesonide : teaching an old dog new tricks for inflammatory bowel disease treatment
2008-01-01 Angelucci, E.; Malesci, A.; Danese, S.
The triggering receptor expressed on myeloid cells (TREM) in inflammatory bowel disease pathogenesis
2014-01-01 Genua, M; Rutella, S; Correale, C; Danese, S
Severe liver injury associated with zafirlukast
2001-01-01 Danese, S; De Vitis, I; Gasbarrini, A
Maintaining the Quality Standards of Care for Inflammatory Bowel Disease Patients During the COVID-19 Pandemic
2020-01-01 Allocca, Mariangela; Fiorino, Gionata; Furfaro, Federica; Gilardi, Daniela; Radice, Simona; D'Amico, Ferdinando; Zilli, Alessandra; Danese, Silvio
Effectiveness of budesonide MMX (Cortiment) for the treatment of mild-to-moderate active ulcerative colitis: study protocol for a prospective multicentre observational cohort study
2016-01-01 Danese, S; Hart, A; Dignass, A; Louis, E; D'Haens, G; Dotan, I; Rogler, G; D'Agay, L; Iannacone, C; Peyrin-Biroulet, L
Acute small-bowel perforation secondary to capsule endoscopy
2008-01-01 Repici, A; Barbon, V; De Angelis, C; Luigiano, C; De Caro, G; Hervoso, C; Danese, S; Preatoni, P; Pagano, N; Comunale, S; Pennazio, M; Rizzetto, M
Commentary: anaemia in inflammatory bowel disease--the most common and ignored extra intestinal manifestation
2014-01-01 Fiorino, G; Allocca, M; Danese, S.
Letter: European Medicines Agency recommendations for allergic reactions to intravenous iron-containing medicines
2014-01-01 Gomollon, F; Chowers, Y; Danese, S; Dignass, A; Nielsen, Oh; Lakatos, Pl; Lees, Cw; Lindgren, S; Lukas, M; Mantzaris, Gj; Michetti, P; Moum, B; Peyrin-Biroulet, L; Toruner, M; van der Woude, J; Weiss, G; Stoevelaar, H; Reinisch, W
Once-daily budesonide MMX in active, mild-to-moderate ulcerative colitis: results from the randomised CORE II study
2014-01-01 Travis, Spl; Danese, S; Kupcinskas, L; Alexeeva, O; D'Haens, G; Gibson, Pr; Moro, L; Jones, R; Ballard, Ed; Masure, J; Rossini, M; Sandborn, Wj
Comparative safety of systemic and low-bioavailability steroids in inflammatory bowel disease: Systematic review and network meta-analysis
2018-01-01 Bonovas, S; Nikolopoulos, Gk; Lytras, T; Fiorino, G; Peyrin-Biroulet, L; Danese, S
Inflammatory Bowel Diseases and COVID-19: The Invisible Enemy
2020-01-01 D'Amico, Ferdinando; Peyrin-Biroulet, Laurent; Danese, Silvio
The role of integrins in the pathogenesis of inflammatory bowel disease: Approved and investigational anti-integrin therapies
2020-01-01 Dotan, Iris; Allez, Matthieu; Danese, Silvio; Keir, Mary; Tole, Swati; Mcbride, Jacqueline
Folate in gastrointestinal health and disease
2012-01-01 Ponziani, Fr; Cazzato, Ia; Danese, S; Fagiuoli, S; Gionchetti, P; Annicchiarico, Be; D'Aversa, F; Gasbarrini, A
Advances in therapeutic interventions targeting the vascular and lymphatic endothelium in inflammatory bowel disease
2013-01-01 D'Alessio, S; Tacconi, C; Fiocchi, C; Danese, S
More on Covid-19 in Immune-Mediated Inflammatory Diseases
2020-01-01 peyrin-Biroulet, Laurent; Danese, Silvio
JAK inhibition using tofacitinib for inflammatory bowel disease treatment: a hub for multiple inflammatory cytokines
2016-01-01 Danese, S; Grisham, M; Hodge, J; Telliez, Jb
The impact of biologics in surgical outcomes in ulcerative colitis
2018-01-01 Argollo, Mc; Kotze, Pg; Spinelli, A; Gomes, Tnf; Danese, S
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| The clinical potential of etrolizumab in ulcerative colitis: hypes and hopes | 1-gen-2016 | Fiorino, G; Gilardi, D; Danese, S | |
| Are We Ready to Abandon Placebo in Randomised Clinical Trials for Inflammatory Bowel Disease? Pros and Cons | 1-gen-2016 | Danese, S; Schabel, E; Masure, J; Plevy, S; Schreiber, S | |
| A liophylized and inactivated colture of Lactobacillus acidophilus increases Helicobacter pylori eradication rate | 1-gen-2000 | Canducci, F; Armuzzi, A; Cremonini, F; Candelli, M; Ojetti, V; Di Campli, C; Gabrielli, M; Danese, S; Pola, P; Gasbarrini, G; Gasbarrini, A | |
| Budesonide : teaching an old dog new tricks for inflammatory bowel disease treatment | 1-gen-2008 | Angelucci, E.; Malesci, A.; Danese, S. | |
| The triggering receptor expressed on myeloid cells (TREM) in inflammatory bowel disease pathogenesis | 1-gen-2014 | Genua, M; Rutella, S; Correale, C; Danese, S | |
| Severe liver injury associated with zafirlukast | 1-gen-2001 | Danese, S; De Vitis, I; Gasbarrini, A | |
| Maintaining the Quality Standards of Care for Inflammatory Bowel Disease Patients During the COVID-19 Pandemic | 1-gen-2020 | Allocca, Mariangela; Fiorino, Gionata; Furfaro, Federica; Gilardi, Daniela; Radice, Simona; D'Amico, Ferdinando; Zilli, Alessandra; Danese, Silvio | |
| Effectiveness of budesonide MMX (Cortiment) for the treatment of mild-to-moderate active ulcerative colitis: study protocol for a prospective multicentre observational cohort study | 1-gen-2016 | Danese, S; Hart, A; Dignass, A; Louis, E; D'Haens, G; Dotan, I; Rogler, G; D'Agay, L; Iannacone, C; Peyrin-Biroulet, L | |
| Acute small-bowel perforation secondary to capsule endoscopy | 1-gen-2008 | Repici, A; Barbon, V; De Angelis, C; Luigiano, C; De Caro, G; Hervoso, C; Danese, S; Preatoni, P; Pagano, N; Comunale, S; Pennazio, M; Rizzetto, M | |
| Commentary: anaemia in inflammatory bowel disease--the most common and ignored extra intestinal manifestation | 1-gen-2014 | Fiorino, G; Allocca, M; Danese, S. | |
| Letter: European Medicines Agency recommendations for allergic reactions to intravenous iron-containing medicines | 1-gen-2014 | Gomollon, F; Chowers, Y; Danese, S; Dignass, A; Nielsen, Oh; Lakatos, Pl; Lees, Cw; Lindgren, S; Lukas, M; Mantzaris, Gj; Michetti, P; Moum, B; Peyrin-Biroulet, L; Toruner, M; van der Woude, J; Weiss, G; Stoevelaar, H; Reinisch, W | |
| Once-daily budesonide MMX in active, mild-to-moderate ulcerative colitis: results from the randomised CORE II study | 1-gen-2014 | Travis, Spl; Danese, S; Kupcinskas, L; Alexeeva, O; D'Haens, G; Gibson, Pr; Moro, L; Jones, R; Ballard, Ed; Masure, J; Rossini, M; Sandborn, Wj | |
| Comparative safety of systemic and low-bioavailability steroids in inflammatory bowel disease: Systematic review and network meta-analysis | 1-gen-2018 | Bonovas, S; Nikolopoulos, Gk; Lytras, T; Fiorino, G; Peyrin-Biroulet, L; Danese, S | |
| Inflammatory Bowel Diseases and COVID-19: The Invisible Enemy | 1-gen-2020 | D'Amico, Ferdinando; Peyrin-Biroulet, Laurent; Danese, Silvio | |
| The role of integrins in the pathogenesis of inflammatory bowel disease: Approved and investigational anti-integrin therapies | 1-gen-2020 | Dotan, Iris; Allez, Matthieu; Danese, Silvio; Keir, Mary; Tole, Swati; Mcbride, Jacqueline | |
| Folate in gastrointestinal health and disease | 1-gen-2012 | Ponziani, Fr; Cazzato, Ia; Danese, S; Fagiuoli, S; Gionchetti, P; Annicchiarico, Be; D'Aversa, F; Gasbarrini, A | |
| Advances in therapeutic interventions targeting the vascular and lymphatic endothelium in inflammatory bowel disease | 1-gen-2013 | D'Alessio, S; Tacconi, C; Fiocchi, C; Danese, S | |
| More on Covid-19 in Immune-Mediated Inflammatory Diseases | 1-gen-2020 | peyrin-Biroulet, Laurent; Danese, Silvio | |
| JAK inhibition using tofacitinib for inflammatory bowel disease treatment: a hub for multiple inflammatory cytokines | 1-gen-2016 | Danese, S; Grisham, M; Hodge, J; Telliez, Jb | |
| The impact of biologics in surgical outcomes in ulcerative colitis | 1-gen-2018 | Argollo, Mc; Kotze, Pg; Spinelli, A; Gomes, Tnf; Danese, S |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista40134
Data di pubblicazione
- In corso di stampa9
- 2020 - 202712186
- 2010 - 201915980
- 2000 - 20097460
- 1990 - 19993486
- 1980 - 1989935
- 1970 - 197977
- 1959 - 19591
Editore
- Elsevier Inc.823
- Elsevier B.V.809
- Springer Science and Business Med...552
- John Wiley and Sons Inc549
- Oxford University Press506
- Lippincott Williams and Wilkins435
- Springer374
- Elsevier Ltd350
- MDPI348
- Springer Nature296
Rivista
- EUROPEAN UROLOGY535
- BLOOD372
- PLOS ONE313
- JOURNAL OF NEUROLOGY291
- EUROPEAN JOURNAL OF HEART FAILURE281
- NEUROLOGY270
- DIGESTIVE AND LIVER DISEASE245
- EUROPEAN HEART JOURNAL225
- MULTIPLE SCLEROSIS219
- SCIENTIFIC REPORTS215
Keyword
- Humans3553
- Male2080
- Female1864
- Middle Aged1472
- Aged1290
- Adult1100
- COVID-19636
- Retrospective Studies628
- Treatment Outcome603
- Prognosis483
Lingua
- eng29490
- ita1971
- fre65
- und55
- spa34
- ger26
- por12
- enm6
- rus6
- grc3
Accesso al fulltext
- no fulltext32003
- reserved4297
- open3722
- partially open104
- embargoed7
- mixed1